Jobs / United States / Novartis Pharmaceuticals Corporation

ITOT Senior Business Analyst

Novartis Pharmaceuticals Corporation · 🇺🇸 Huningue

Sponsorship verdict

Sponsorship possible

One solid signal, not two — worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
  • Confirmed live todayWhen a source last listed this job as open.

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.

Start free →

Or apply yourself on the official page →

Sponsor Radar — Novartis Pharmaceuticals Corporation

75 H-1B filings certified since Oct 2025

The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).

Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Novartis Pharmaceuticals Corporation →

About the role

Salary Range: €49,000.00 - €91,000.00   Job Description Summary Location: Huningue, France #LI-Hybrid Internal job title: Sr.Specialist DDIT OPS Automation Engineer This role is based in Huningue. Novartis is unable to offer relocation support for this role: please only apply if this location is accessible for you. About the Role: Step into a rare opportunity to shape a site from the ground up. As the Senior Automation Engineer / ITOT specialist (m/f/d) in Huningue, you will play a pivotal role in building and enabling Novartis’ new Radioligand Therapy manufacturing site, acting as the first on-site ITOT presence in France. This role goes beyond day-to-day operations: you will partner closely with site leadership, engineering, and external suppliers to deliver critical capital projects, establish compliant information technology and operational technology systems, and support validation activities in a highly regulated environment. If you thrive in complex, fast-moving settings, enjoy taking ownership, and want to see the tangible impact of your work on a growing site, this role offers exceptional visibility, responsibility, and long-term career scope. Lieu : Huningue, France Titre du poste interne : Sr. Spécialiste DDIT OPS en ingénierie de l’automatisation.) Aide à la mobilité : Ce poste est basé à Huningue, France. Novartis n’est pas en mesure de proposer une aide à la mobilité. Merci de postuler uniquement si le site est facilement accessible pour vous. Saisissez une opportunité unique de participer à la construction d’un site industriel dès sa création. En tant qu’Ingénieur Senior en Automatisation / Spécialiste IT/OT (H/F) à Huningue, vous jouerez un rôle central dans la mise en place et le développement du nouveau site de production de Radioligand Therapy (RLT) de Novartis. Vous serez le premier référent IT/OT sur site en France et contribuerez directement à l’établissement des fondations numériques et industrielles nécessaires à la réussite de cette nouvelle installation. Ce poste va bien au-delà des opérations quotidiennes. Vous travaillerez en étroite collaboration avec la direction du site, les équipes d’ingénierie et les fournisseurs externes afin de déployer des projets d’investissement stratégiques, mettre en place des systèmes conformes d’informatique industrielle (IT) et de technologies opérationnelles (OT), et soutenir les activités de qualification et de validation dans un environnement hautement réglementé. Si vous aimez évoluer dans des environnements complexes et dynamiques, prendre des responsabilités, piloter des sujets de bout en bout et constater l’impact concret de votre travail sur un site en pleine croissance, ce poste vous offrira une visibilité exceptionnelle, un haut niveau de responsabilité ainsi que de réelles perspectives d’évolution à long terme.   Job Description Key Responsibilities • Act as the on-site information technology and operational technology lead supporting the build-out of the Huningue manufacturing site • Coordinate suppliers and partners across information technology and operational technology during construction, installation, and commissioning phases • Lead validation and testing activities, ensuring traceability between user requirements, specifications, and compliant system delivery • Partner with site leadership and engineering teams to deliver capital projects on time, within scope, and to quality standards • Ensure compliance with security, quality, health, safety, and environmental standards across all ITOT activities • Support transition from project execution into stable operations, enabling reliable day-to-day site performance • Communicate progress, risks, and priorities clearly to senior stakeholders and cross-functional teams   Essential requirements:

View the official posting →

Source: Employer career site (Workday) First seen: 2026-10-01 Last confirmed: 2026-10-04 How our data works → Report this job

Similar opportunities